A citation-based method for searching scientific literature

Gregory J Tsongalis, M Rabie Al Turkmani, Michael Suriawinata, Michael J Babcock, Kristi Mitchell, Yi Ding, Lisa Scicchitano, Adrian Tira, Lela Buckingham, Sara Atkinson, Amy Lax, Dara L Aisner, Kurtis D Davies, Holly N Wood, Stacey S O'Neill, Edward A Levine, Judy Sequeira, Shuko Harada, Gina DeFrank, Ravikumar Paluri, Bradford A Tan, Heather Colabella, Christopher Snead, Marcia Cruz-Correa, Virginia Ramirez, Arnaldo Rojas, Huiya Huang, Alexander C Mackinnon, Fernando U Garcia, Sharon M Cavone, Mutasim Elfahal, Gyorgy Abel, Mohammad A Vasef, Andrew Judd, Mark W Linder, Khaled Alkhateeb, William L Skinner, Ralph Boccia, Kashyap Patel. Am J Clin Pathol 2020
Times Cited: 6







List of co-cited articles
23 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Solène M Evrard, Estelle Taranchon-Clermont, Isabelle Rouquette, Samuel Murray, Sebastian Dintner, Yun-Chung Nam-Apostolopoulos, Beatriz Bellosillo, Mar Varela-Rodriguez, Ernest Nadal, Klaus H Wiedorn,[...]. J Mol Diagn 2019
27
50

Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results.
Amir Momeni-Boroujeni, Paulo Salazar, Tao Zheng, Nana Mensah, Ivelise Rijo, Snjezana Dogan, JinYuan Yao, Christine Moung, Chad Vanderbilt, Jamal Benhamida,[...]. J Mol Diagn 2021
10
50

Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing.
Matthias Van Haele, Sara Vander Borght, An Ceulemans, Michiel Wieërs, Sofie Metsu, Xavier Sagaert, Birgit Weynand. J Clin Pathol 2020
23
50

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform.
Cornelis Bisschop, Arja Ter Elst, Lisette J Bosman, Inge Platteel, Mathilde Jalving, Anke van den Berg, Arjan Diepstra, Bettien van Hemel, Gilles F H Diercks, Geke A P Hospers,[...]. Melanoma Res 2018
31
33

EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay.
Caterina De Luca, Gianluca Gragnano, Pasquale Pisapia, Elena Vigliar, Umberto Malapelle, Claudio Bellevicine, Giancarlo Troncone. J Clin Pathol 2017
40
33

Evaluation of the Idylla KRAS and NRAS mutation test in colorectal cancer tissue.
Jamal Zekri, Mohammed A Baghdadi, Hosam Alardati, Hamoud Khallaf, Juma H Kabanja. Exp Mol Pathol 2019
4
50

Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer.
Iván Prieto-Potin, Clara Montagut, Beatriz Bellosillo, Matthew Evans, Matthew Smith, Linea Melchior, Werner Reiltin, Michael Bennett, Veronica Pennati, Francesca Castiglione,[...]. J Mol Diagn 2018
19
33

Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
Richard Colling, Hollie Bancroft, Gerald Langman, Elizabeth Soilleux. Virchows Arch 2019
19
33

New approaches to molecular monitoring in CML (and other diseases).
Jerald Radich, Cecilia Yeung, David Wu. Blood 2019
12
33

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
33

Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.
Ana Velasco, Fatma Tokat, Jesper Bonde, Nicola Trim, Elisabeth Bauer, Adam Meeney, Wendy de Leng, George Chong, Véronique Dalstein, Lorand L Kis,[...]. Virchows Arch 2021
14
33

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
33

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Robert M Samstein, Chung-Han Lee, Alexander N Shoushtari, Matthew D Hellmann, Ronglai Shen, Yelena Y Janjigian, David A Barron, Ahmet Zehir, Emmet J Jordan, Antonio Omuro,[...]. Nat Genet 2019
33

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
Mercedes Delgado-García, Birgit Weynand, Lourdes Gómez-Izquierdo, María José Hernández, Ángela María Blanco, Mar Varela, Xavier Matias-Guiu, Ernest Nadal, Bélgica Márquez-Lobo, Ana Alarcão,[...]. BMC Cancer 2020
10
33

NCCN Guidelines Insights: Melanoma, Version 3.2016.
Daniel G Coit, John A Thompson, Alain Algazi, Robert Andtbacka, Christopher K Bichakjian, William E Carson, Gregory A Daniels, Dominick DiMaio, Ryan C Fields, Martin D Fleming,[...]. J Natl Compr Canc Netw 2016
64
33

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view.
Glen Le Flahec, Briac Guibourg, Pascale Marcorelles, Arnaud Uguen. J Clin Pathol 2017
8
33

Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.
Linea Melchior, Morten Grauslund, Beatriz Bellosillo, Clara Montagut, Erica Torres, Ester Moragón, Isabel Micalessi, Johan Frans, Veerle Noten, Claire Bourgain,[...]. Exp Mol Pathol 2015
35
33

Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue.
Louise Johnston, Michael Power, Philip Sloan, Anna Long, Angela Silmon, Ben Chaffey, Andrea Jane Lisgo, Liam Little, Ellen Vercauteren, Torben Steiniche,[...]. J Clin Pathol 2018
19
33


Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day.
Laetitia Lambros, Charline Caumont, Briac Guibourg, Fanny Barel, Isabelle Quintin-Roué, Pascale Marcorelles, Jean-Philippe Merlio, Arnaud Uguen. J Clin Pathol 2017
32
33


Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine.
Huiya Huang, Stephanie Springborn, Kiefer Haug, Kaitlyn Bartow, Hasan Samra, Smitha Menon, Alexander C Mackinnon. J Mol Diagn 2019
19
33


KRAS-Mutant non-small cell lung cancer: From biology to therapy.
Irene Ferrer, Jon Zugazagoitia, Stephan Herbertz, William John, Luis Paz-Ares, Gerald Schmid-Bindert. Lung Cancer 2018
148
16

Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study.
Caterina De Luca, Floriana Conticelli, Alvaro Leone, Gianluca Gragnano, Maria Salatiello, Pasqualina Galasso, Pasquale Pisapia, Lucia Rosalba Grillo, Antonino Iaccarino, Elena Vigliar,[...]. J Clin Pathol 2019
13
16

Pre-clinical validation of a next generation sequencing testing panel.
Jessica Lüsebrink, Monika Pieper, Ramona-Liza Tillmann, Michael Brockmann, Oliver Schildgen, Verena Schildgen. Exp Mol Pathol 2018
5
20


EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation.
Jianlin Xu, Haitang Yang, Bo Jin, Yuqing Lou, Yanwei Zhang, Xueyan Zhang, Hua Zhong, Huiming Wang, Dan Wu, Baohui Han. Sci Rep 2016
6
16

Detailed overview on the mutations detected by and the sensitivity of the GeneReader NGS sequencing platform.
Jessica Lüsebrink, Monika Pieper, Ramona-Liza Tillmann, Michael Brockmann, Oliver Schildgen, Verena Schildgen. Data Brief 2018
4
25

Nanopore Targeted Sequencing for Rapid Gene Mutations Detection in Acute Myeloid Leukemia.
Cosimo Cumbo, Crescenzio Francesco Minervini, Paola Orsini, Luisa Anelli, Antonella Zagaria, Angela Minervini, Nicoletta Coccaro, Luciana Impera, Giuseppina Tota, Elisa Parciante,[...]. Genes (Basel) 2019
15
16

Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target.
Paul A VanderLaan, Yigu Chen, Marcello DiStasio, Deepa Rangachari, Daniel B Costa, Yael K Heher. Clin Lung Cancer 2018
8
16

Building Containerized Workflows Using the BioDepot-Workflow-Builder.
Ling-Hong Hung, Jiaming Hu, Trevor Meiss, Alyssa Ingersoll, Wes Lloyd, Daniel Kristiyanto, Yuguang Xiong, Eric Sobie, Ka Yee Yeung. Cell Syst 2019
6
16


Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens.
A J Dawson, J McGowan-Jordan, J Chernos, J Xu, J Lavoie, J C Wang, M Steinraths, S Shetty. Curr Oncol 2011
4
25

Laboratories as the Core for Health Systems Building.
Danny A Milner, E Blair Holladay. Clin Lab Med 2018
10
16

Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory.
Samuel P Strom, Hane Lee, Kingshuk Das, Eric Vilain, Stanley F Nelson, Wayne W Grody, Joshua L Deignan. Genet Med 2014
92
16

Gene fusion analysis in renal cell carcinoma by FusionPlex RNA-sequencing and correlations of molecular findings with clinicopathological features.
Maria S Tretiakova, Wenjing Wang, Yu Wu, Scott S Tykodi, Lawrence True, Yajuan J Liu. Genes Chromosomes Cancer 2019
15
16

Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications.
Xin Xiao, Cassandra C Garbutt, Francis Hornicek, Zheng Guo, Zhenfeng Duan. Cancer Treat Rev 2018
23
16

Predicting Chemotherapy Resistance in AML.
Cecilia C S Yeung, Jerald Radich. Curr Hematol Malig Rep 2017
11
16

Assessing the performance of the Oxford Nanopore Technologies MinION.
T Laver, J Harrison, P A O'Neill, K Moore, A Farbos, K Paszkiewicz, D J Studholme. Biomol Detect Quantif 2015
233
16

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration.
Helga Thorvaldsdóttir, James T Robinson, Jill P Mesirov. Brief Bioinform 2013
16

Nanopore sequencing and assembly of a human genome with ultra-long reads.
Miten Jain, Sergey Koren, Karen H Miga, Josh Quick, Arthur C Rand, Thomas A Sasani, John R Tyson, Andrew D Beggs, Alexander T Dilthey, Ian T Fiddes,[...]. Nat Biotechnol 2018
780
16


Nextflow enables reproducible computational workflows.
Paolo Di Tommaso, Maria Chatzou, Evan W Floden, Pablo Prieto Barja, Emilio Palumbo, Cedric Notredame. Nat Biotechnol 2017
505
16

Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors.
Marjan Yaghmaie, Cecilia Cs Yeung. Curr Hematol Malig Rep 2019
23
16

Performance of neural network basecalling tools for Oxford Nanopore sequencing.
Ryan R Wick, Louise M Judd, Kathryn E Holt. Genome Biol 2019
347
16


Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Lawrence J Jennings, Maria E Arcila, Christopher Corless, Suzanne Kamel-Reid, Ira M Lubin, John Pfeifer, Robyn L Temple-Smolkin, Karl V Voelkerding, Marina N Nikiforova. J Mol Diagn 2017
316
16

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
16

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
Hartmut Döhner, Elihu H Estey, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Alan K Burnett, Hervé Dombret, Pierre Fenaux, David Grimwade, Richard A Larson,[...]. Blood 2010
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.